| Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis (NCT02988778) | Eurofarma Laboratorios S.A. | 2019-10-08 |
| Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age (NCT03286049) | Istituto per la Ricerca e l'Innovazione Biomedica | 2018-01-10 |
| Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis (NCT02972866) | Eurofarma Laboratorios S.A. | 2016-06-01 |
| Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis. (NCT02653339) | Peking Union Medical College Hospital | 2016-06-01 |
| Repeated Dosing Clinical Trial of HL151 (NCT02686294) | Hanlim Pharm. Co., Ltd. | 2016-02-16 |
| Single Dosing Clinical Trial of HL151 (NCT02682745) | Hanlim Pharm. Co., Ltd. | 2016-01-15 |
| Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR (NCT02443805) | Stallergenes Greer | 2015-09-29 |
| Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 (NCT02498509) | Chong Kun Dang Pharmaceutical | 2015-05-01 |
| Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis (NCT02339714) | Zhao Hong | 2015-03-01 |
| Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) (NCT01700192) | ALK-Abelló A/S | 2013-01-01 |
| Probiotic Administration and Perennial Allergic Rhinitis (NCT01779895) | Société des Produits Nestlé (SPN) | 2012-12-01 |
| A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) (NCT01644617) | ALK-Abelló A/S | 2012-10-01 |
| Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) (NCT01678807) | ALK-Abelló A/S | 2012-10-01 |
| Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis (NCT01630135) | GlaxoSmithKline | 2012-06-01 |
| Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers (NCT01216384) | Boehringer Ingelheim | 2010-10-01 |
| Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) (NCT01135134) | Organon and Co | 2010-06-01 |
| Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population (NCT01172613) | Siriraj Hospital | 2010-06-01 |
| Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) (NCT01134705) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-05-01 |
| A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1) (NCT01165424) | Organon and Co | 2010-04-01 |
| Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais (NCT01115595) | Pongsakorn Tantilipikorn | 2010-03-01 |
| Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis (NCT00988247) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-10-31 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis (NCT01231464) | GlaxoSmithKline | 2009-09-01 |
| A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis (NCT01270958) | GlaxoSmithKline | 2009-08-01 |
| A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures (NCT01199757) | GlaxoSmithKline | 2009-07-10 |
| Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) (NCT00829985) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis (NCT00682643) | GlaxoSmithKline | 2008-06-01 |
| A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis (NCT00730756) | GlaxoSmithKline | 2008-03-01 |
| Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) (NCT00761527) | Organon and Co | 2008-03-01 |
| A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis (NCT00609674) | GlaxoSmithKline | 2008-01-01 |
| Flixonase Safety in Patients With Allergic Rhinitis (AR) (NCT01077609) | GlaxoSmithKline | 2008-01-01 |
| Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. (NCT00570492) | GlaxoSmithKline | 2007-11-26 |
| A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber (NCT00848965) | GlaxoSmithKline | 2007-10-01 |
| Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS (NCT00519636) | GlaxoSmithKline | 2007-08-01 |
| Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS (NCT00539006) | GlaxoSmithKline | 2007-08-01 |
| Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis (NCT00490204) | GlaxoSmithKline | 2007-07-27 |
| Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) (NCT00449072) | Sanofi | 2007-03-01 |
| Fluticasone Nasal Spray Patient Preference Study (NCT00398476) | GlaxoSmithKline | 2006-12-01 |
| Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) (NCT00806754) | AstraZeneca | 2006-11-01 |
| Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber (NCT00404586) | GlaxoSmithKline | 2006-09-11 |
| Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) (NCT00406783) | Organon and Co | 2006-08-01 |
| Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) (NCT00346775) | GlaxoSmithKline | 2006-05-01 |
| Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) (NCT00289198) | GlaxoSmithKline | 2006-02-07 |
| Long Term Safety Of GW685698X Via Nasal Biopsy (NCT00224523) | GlaxoSmithKline | 2005-09-01 |
| Perennial Allergic Rhinitis In Pediatric Subjects (NCT00257595) | GlaxoSmithKline | 2005-08-01 |
| Study Of Perennial Allergic Rhinitis In Pediatrics (NCT00253058) | GlaxoSmithKline | 2005-07-01 |
| Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus (NCT02238236) | Boehringer Ingelheim | 2005-05-01 |
| LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) (NCT00160589) | UCB Pharma | 2005-04-01 |
| ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) (NCT00160680) | UCB S.A. - Pharma Sector | 2005-03-01 |
| Seasonal Allergic Rhinitis In Pediatric Subjects (NCT00107757) | GlaxoSmithKline | 2005-03-01 |
| Perennial Allergic Rhinitis Study In Pediatric Subjects (NCT00108914) | GlaxoSmithKline | 2005-02-01 |
| A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics (NCT00116883) | GlaxoSmithKline | 2005-02-01 |
| Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) (NCT00779740) | Organon and Co | 2005-02-01 |
| A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults (NCT00116818) | GlaxoSmithKline | 2005-01-01 |
| A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). (NCT00103454) | GlaxoSmithKline | 2005-01-01 |
| Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) (NCT00659048) | AstraZeneca | 2004-12-01 |
| EWO1 in Persistent Allergic Rhinitis Patients (NCT00153595) | China Medical University Hospital | 2004-11-01 |
| To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) (NCT00658918) | AstraZeneca | 2004-09-01 |
| A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) (NCT00779545) | Organon and Co | 2004-04-08 |
| Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet (NCT02238223) | Boehringer Ingelheim | 2004-04-01 |
| To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) (NCT00659750) | AstraZeneca | 2003-12-01 |
| Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic (NCT00159523) | Norwegian University of Science and Technology | 2003-12-01 |
| The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) (NCT00092118) | Organon and Co | 2003-10-01 |
| Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults (NCT00839189) | University of North Carolina, Chapel Hill | 2002-10-01 |
| Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis (NCT00639587) | UCB Pharma | 2002-08-01 |
| Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) (NCT00092105) | Organon and Co | 2002-04-01 |
| Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis (NCT00741897) | Sanofi | 2002-03-01 |
| WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis (NCT02182544) | Boehringer Ingelheim | 2001-06-01 |
| Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis (NCT02182518) | Boehringer Ingelheim | 2000-05-01 |